Instrument Inactif

Cours South Shore Resources, Inc. Other OTC

Actions

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.	14/03
Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth	07/03
StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast	29/02
Strainsforpains Inc. Announces Corporate Update	23/02
Strainsforpains, Inc. secures its largest orders to date from NYC establishments	19/01

Dirigeants	Titre	Age	Depuis
Yehoshua Shainberg CEO	Chief Executive Officer	-	29/08/16

Secteur

	Varia. 1 janv.	Capi.
SAMSUNG BIOLOGICS CO.,LTD.	+6,58%	39,05 Md
BIOGEN INC.	-11,57%	33,74 Md
UCB	+79,15%	28,54 Md
BIOMARIN PHARMACEUTICAL INC.	-14,73%	15,59 Md
INCYTE CORPORATION	-6,00%	13,69 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,55%	11,44 Md
ALTEOGEN INC.	+166,50%	10,66 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54,80%	9,27 Md
SWEDISH ORPHAN BIOVITRUM AB	+4,19%	9,13 Md